Regulation of signal transduction pathways by mood-stabilizing agents: Implications for the delayed onset of therapeutic efficacy

Journal of Clinical Psychiatry

Volumn 57, Issue SUPPL. 13, 1996, Pages 34-46

  Manji, Husseini K ^a   Chen, Guang ^a   Hsiao, John K ^b   Risby, Emile D ^c   Masana, Monica I ^d   Potter, William Z ^e  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

^c EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d NORTHWESTERN UNIVERSITY   (United States)

^e ELI LILLY AND COMPANY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENYLATE CYCLASE; CARBAMAZEPINE; GUANINE NUCLEOTIDE BINDING PROTEIN; LITHIUM; PROTEIN KINASE C; TRANSCRIPTION FACTOR; VALPROIC ACID;

ADENOSINE DIPHOSPHATE RIBOSYLATION; ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DNA BINDING; DOSE TIME EFFECT RELATION; DRUG EFFICACY; DRUG MECHANISM; ENZYME ACTIVITY; HUMAN; MANIC DEPRESSIVE PSYCHOSIS; NONHUMAN; PRIORITY JOURNAL; PROPHYLAXIS; PROTEIN PROCESSING; RAT; SIGNAL TRANSDUCTION;

EID: 0030455770     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (109)

1. Weissman MM, Leaf PJ, Tischler GL, et al. Affective disorders in five United States communities. Psychol Med 1988;18:141-153
2. Goodwin FK, Jamison KR. Manie-Depressive Illness. New York, NY: Oxford University Press; 1990
3. Reifman A, Wyatt RJ. Lithium: a brake in the rising cost of mental illness. Arch Gen Psychiatry 1980;37:385-388
4. Manji HK, Potter WZ, Lenox RH. Signal transduction pathways: molecular targets for lithium's actions. Arch Gen Psychiatry 1995;52:531-543
5. Kramlinger KG, Post RM. The addition of lithium to carbamazepine: antidepressant efficacy in treatment-resistant mania. Arch Gen Psychiatry 1989;46:794-800
6. Chou JC. Recent advances in treatment of acute mania. J Clin Psychopharmacol 1991;11:3-21
7. Keck PE Jr, McElroy SL, Bennett JA. Health-economic implications of the onset of action of antimanic agents. J Clin Psychiatry 1996;57(suppl 13):13-18
8. Bowden CL, Karren NU. Dosing strategies and time course of response to antimanic drugs. J Clin Psychiatry 1996;57(suppl 13):4-9
9. Post RM, Ballenger JC, Uhde TW. et al. Efficacy of carbamazepine in manic-depressive illness: implications for underlying mechanisms. In: Post RM, Ballenger JC, eds. Neurobiology of Mood Disorders. Baltimore, Md: Williams & Wilkins; 1984:777-816
10. Lenox RH, Manji HK. Lithium. In: Nemeroff CB, Schatzberg AF, eds. American Psychiatric Press Textbook of Psychopharmacology; 1995
11. Post RM, Weiss SB, Chuang DM. Mechanism of action of anticonvulsanls in affective disorders: comparisons with lithium. J Clin Psychopharmacol 1993;12(1,suppl):23S-35S
12. Rogawski MA, Porter RJ. Antiepileptic drugs: pharmacological mechanisms and clinical efficacy with consideration of promising development stage compounds. Pharmacol Rev 1990;42:223-286
13. Risby ED, Hsiao JK, Manji HK, et al. The mechanisms of action of lithium. Arch Gen Psychiatry 1991;48:513-524
14. Hsiao JK, Argen H, Bartko JJ, et al. Monoamine neurotransmitter interactions and the prediction of antidepressant response. Arch Gen Psychiatry 1987;44:1078-1083
15. Hsiao JK, Colison J, Bartko JJ, et al. Monoamine neurotransmitter interactions in drug-free and neuroleptic-treated schizophrenics. Arch Gen Psychiatry 1993;50:606-614
16. Manji HK. G proteins: implications for psychiatry. Am J Psychiatry 1992;149:746-760
17. Meltzer HY. The importance of serotonin-dopamine interactions in the action of clozapine. Br J Psychiatry 1992;160(suppl 17):22-29
18. Bourne HR, Nicoll R. Molecular machines integrate coincident synaptic signals. Cell 1993;72:65-75
19. Ross EM. Signal sorting and amplification through G protein-coupled receptors. Neuron 1989;3:141-152
20. Taylor CW. The role of G proteins in transmembrane signaling. Biochem J 1990;272:1-13
21. Jope RS, Williams MB. Lithium and brain signal transduction systems. Biochem Pharmacol 1994;7:429-441
22. Lachman HM, Papolos DF. Abnormal signal transduction: a hypothetical model for bipolar affective disorder. Life Sci 1991;45:1413-1426
23. Hudson CJ, Young LT, Li PP, et al. CNS signal transduction in the pathophysiology and pharmacotherapy of affective disorders and schizophrenia. Synapse 1993;3:278-293
24. Chen G, Manji HK, Hawver DB, et al. Chronic sodium valproate selectively decreases protein kinase C α and ε in vitro. J Neurochem 1994;63:2361-2364
25. Chen G, Yuan P, Hawver D, et al. Increase in AP-1 transcription factor DNA binding activity by valproic acid. Neuropsychopharmacology. In press
26. Lenox RH, McNamara RK, Watterson JM, et al. Myristoylated alanine-rich C kinase substrate (MARCKS): a molecular target for the therapeutic action of mood stabilizers in brain? J Clin Psychiatry 1996;57(suppl 13):23-31
27. Suppes T, Baldessarini RJ, Faedda GL, et al. Risk of recurrence following discontinuation of lithium treatment in bipolar disorder. Arch Gen Psychiatry 1991;48:1082-1088
28. Manji HK, Potter WZ. Emerging strategies in affective disorders. In: Pullan L, Patel J, eds. Emerging Strategies in Neurotherapeutics. Totowa, NJ: Humana Press: 1995:35-83
29. Avissar S, Schreiber G, Danon A, et al. Lithium inhibits adrenergic and cholinergic increases in GTP binding in rat cortex. Nature 1988;331:440-442
30. Ellis J, Lenox RH. Receptor coupling to G proteins: interactions not affected by lithium. Lithium 1991;2:141-147
31. Mork A, Geisler A, Holland P. Effects of lithium on second messenger systems in the brain. Pharmacol Toxicol 1992:71(suppl 1):4-17
32. Masana MI, Bitran JA, Hsiao JK, et al. In vivo evidence that lithium inactivates Gi modulation of adenylate cyclase in brain. J Neurochem 1992;59:200-205
33. Hsiao JK, Manji HK, Chen GA, et al. Lithium administration modulates platelet Gi in humans. Life Sci 1992;50:227-233
34. Ui M. Pertussis toxin as a valuable probe for G protein involvement in signal transduction. In: Moss J, Vaughn M, eds. ADP-Ribosylation Toxins and G Proteins. Washington, DC: American Society for Microbiology; 1990
35. Turkka J, Bitran JA, Manji HK, et al. Effects of chronic lithium on agonist and antagonist binding to β adrenergic receptors of rat brain. Lithium 1992;3:43-47
36. Manji HK, Bitran JA, Masana MI, et al. Signal transduction modulation by lithium: cell culture, cerebral microdialysis and human studies. Psychopharmacol Bull 1991;27:199-208
37. Manji HK, Hsiao JK, Risby ED, et al. The mechanisms of action of lithium. Arch Gen Psychiatry 1991;48:505-512
38. Mork A, Geisler A. Effects of GTP on hormone-stimulated adenylate cyclase activity in cerebral cortex, striatum, and hippocampus from rats treated chronically with lithium. Biol Psychiatry 1989;26:279-288
39. Garcia-Sainz JA, Gutierrez VG. Activation of protein kinase C alters the interaction of alpha 2-adrenoceptors and the inhibitory GTP-binding protein (Gi) in human platelets. FEBS Lett 1989;257:427-430
40. Halenda SP, Volpi M, Zavoico GB, et al. Effects of thrombin, phorbol myristate acetate, and postaglandin D2 on 40-41 kDa protein that is ADP ribosylated by pertussis toxin in platelets. FEBS Lett 1986;204:341-346
41. Houslay MD. "Crosswalk": a pivotal role for protein kinase C in modulating relationships between signal transduction pathways. Eur J Biochem 1991;195:9-27
42. Sagi-Eisenberg R. GTP-binding proteins as possible targets for protein kinase C action. Trends Biochem Sci 1989;14:355-357
43. Nishizuka Y. Intracellular signaling by hydrolysis of phospholipids and activation of protein kinase C. Science 1992;258:607-614
44. Li PP, Tam YK, Young LT, et al. Lithium decreases Gs, Gi-1 and Gi-2 alpha-subunit mRNA levels in rat cortex. Eur J Pharmacol 1991;206:165-166
45. Li PP, Sibony D, Green MA, et al. Lithium modulation of phosphoinositide signaling system in rat cortex: selective effect on phorbol ester binding. J Neurochem 1993;61:1722-1730
46. Colin SF, Chang HC, Mollner S, et al. Chronic lithium regulates the expression of adenylate cyclase and Gi-protein alpha subunit in rat cerebral cortex. Proc Natl Acad Sci U S A 1991;88:10634-10637
47. Stabel S, Parker PJ. Protein kinase C. Pharmacol Ther 1991;51:71-95
48. Huang KP. The mechanism of protein kinase C activation. Trends Neurosci 1989;12:425-432
49. Manji HK, Lenox RH. Long-term action of lithium: a role for transcriptional and posttranscriptional factors regulated by protein kinase C. Synapse 1994;16:11-28
50. Anderson SMP, Godfrey PP, Grahame-Smith DG. The effects of phorbol esters and lithium on 5-HT release in rat hippocampal slices [abstract]. Br J Pharmacol 1988;93:96
51. Wang HY, Friedman E. Lithium inhibition of protein kinase C activation-induced serotonin release. Psychopharmacology (Berl) 1989;99:213-218
52. Casebolt TL, Jope RS. Effects of chronic lithium treatment on protein kinase C and cyclic AMP-dependent protein phosphorylation. Biol Psychiatry 1991;29:233-243
53. Robinson PJ. The role of protein kinase C and its neuronal substrates dephosphin, B-50, and MARCKS in neurotransmitter release. Mol Neurobiol 1991;5:87-130
54. DeGrann PN, Schrama LH, Heemskerk FM, et al. The role of protein kinase C substrate B-50 (GAP-43) in neurotransmitter release and long-term potentiation. Adv Exp Med Biol 1990;268:347-358
55. Lenox RH, Watson DG, Patel J, et al. Chronic lithium administration alters a prominent PKC substrate in rat hippocampus. Brain Res 1991;570:333-340
56. Manji HK, Etcheberrigaray R, Chen G, et al. Lithium dramatically decreases membrane-associated PKC in the hippocampus: selectivity for the alpha isozyme. J Neurochem 1993;61:2303-2310
57. Ben-Schlomo H, Sigmund O, Stabel S, et al. Preferential release of cate-cholamine from permeabilized PC 12 cells by α and β type protein kinase C subspecies. Biochem J 1991;280:65-69
58. Oda T, Shearman MS, Nishizuka Y. Synaptosomal protein kinase C subspecies: B. down-regulation promoted by phorbol ester and its effect on evoked norepinephrine release. J Neurochem 1991;56:1263-1269
59. Masana MI, Chen G, Shorts L, et al. Selective modulation of PKC isozymes by lithium: effects on intracellular cross-talk. Neurochem Int. In press
60. Young S, Parker PJ, Ullrich A, et al. Down-regulation of protein kinase C is due to an increased rate of degradation. Biochem J 1987;24:775-779
61. Kishimoto A, Mikawa K, Hashimoto K, et al. Limited proteolysis of protein kinase C subspecies by calcium-dependent neutral protease (calpain). J Biol Chem 1989;264:4088-4092
62. Isakov N, McMahon P, Altman A. Selective post-transcriptional down-regulation of protein kinase C isoenzymes in leukemic T cells chronically treated with phorbol ester. J Biol Chem 1990;265:2091-2097
63. Borner C, Guadagno SN, Fabbro D, et al. Expression of four protein kinase C isoforms in rat fibroblasts: distinct subcellular distribution and regulation by calcium and phorbol esters. J Biol Chem 1992;267:12892-12899
64. Leli U, Shea TB, Catalano A. et al. Differential expression and subcellular localization of protein kinase C α, β, γ, δ, and ε isofroms in Sh-SY5Y neuroblastoma cells: modifications during differentiation. J Neurochem 1993; 60:289-298
65. Leli U, Hauser G. Lithium modifies diacylglycerol levels and protein kinase C in neuroblastoma cells. In: Abstracts of the 8th International Conference on Second Messengers and Phosphoproteins; July 1992; Glasgow, Scotland. Abstract Z187F:23
66. Li X, Jope RS. Selective inhibition of the expression of signal transduction proteins by lithium in nerve growth factor-differentiated PC12 cells. J Neurochem 1995;65(6):2500-2508
67. Jope RS, Williams MB, Li X. et al. Lithium modulates neuronal signal transduction systems. In: Manji HK, Bowden CL, Belmaker RH, eds. Mechanisms of Antibipolar Treatments. Washington, DC: American Psychiatric Press. In press
68. Drummond AH, Raebum CA. The interaction of lithium with thyrotropin releasing hormone-stimulated lipid metabolism in GH3 pituitary tumor cells. Biochem J 1984;224:129-136
69. Downes CP, Stone MA. Lithium-induced reduction in intracellular inositol supply in cholinergically stimulated parotid gland. Biochem J 1986; 34:199-204
70. 3H] CDP-diacyiglycerol in human platelets. Eur J Pharmacol 1990; 188:273-276
71. Brami BA, Leli U, Hauser G. Influence of lithium on second messenger accumulation in NG108-15 cells. Biochem Biophys Res Commun 1991; 174:606-612
72. Brami BA, Leli U, Hauser G. Origin of the diacylglycerol produced in excess of inositol phosphates by lithium in NG108-15 cells [abstract]. J Neurochem 1991;57(suppl):S9
73. Rana RS, Hokin LE. Role of phosphoinositides in transmembrane signaling. Physiol Rev 1990;70:115-164
74. Fisher SK, Heacock AM, Agranoff BW. Inositol lipids and signal transduction in the nervous system: an update. J Neurochem 1992;58:18-38
75. Erusalimsky JD, Brooks SF, Herget T, et al. Molecular cloning and characterization of the acidic 80-kDa protein kinase C substrate from rat brain. J Biol Chem 1991;266:7073-7080
76. Linder D, Gschwendt M, Marks F. Phorbol ester-induced down-regulation of the 80-kDa myristoylated alanine-rich C-kinase substrate-related protein in Swiss 3T3 fibroblasts. J Biol Chem 1992;267:24-26
77. Manji HK, Bersudsky Y, Chen G, et al. Modulation of protein kinase C isozymes and substrates by lithium: the role of myo-inositol. Neuropsy-chopharmacology 1996;15:370-381
78. Bourgeois BFD. Valproate: clinical use. In: Levy R, Mattson R, Meldrum B, et al, eds. Antiepileptic. 3rd ed. New York, NY: Raven Press; 663-641
79. Bowden CL. Role of newer medications for bipolar disorder. J Clin Psychopharmacol 1996;16(1,suppl):48S-56S
80. McElroy SL, Keck PE Jr, Pope HG Jr, et al. Valproate in the treatment of bipolar disorder: literature review and clinical guidelines. J Clin Psychopharmacol 1992;12(1,suppl):42S-52S
81. Bowden CL, Brugger AM, Swann AC, et al. Efficacy of divalproex vs lithium and placebo in the treatment of mania. JAMA 1994;271:918-924
82. Loscher W. Effects of the antiepileptic drug valproate on metabolism and function of inhibitory and excitatory amino acids in the brain. Neurochem Res 1993;18:485-502
83. Chen G, Manji HK, Hawver DB, et al. Chronic sodium valproate selectively decreases protein kinase C alpha and epsilon in vitro. J Neurochem 1994;63:2361-2365
84. Regan CM. Therapeutic levels of sodium valproate inhibit mitotic indices in cells of neural origin. Brain Res 1985;347:394-398
85. Martin ML, Regan CM. The anticonvulsant sodium valproate specifically induces the expression of a rat glial heat shock protein which is identified as the collagen type IV receptor. Brain Res 1988;459:131-137
86. Freidman E, Hoau YW, Levinson D, et al. Altered platelet protein kinase C activity in bipolar affective disorder, manic episode. Biol Psychiatry 1993;33:520-525
87. Post RM, Weiss SR, Clark M, et al. Lithium, carbamazepine and valproate in affective illness: biochemical and neurobiological mechanisms. In: Manji HK, Bowden CL, Belmaker RH, eds. Mechanisms of Antibipolar Treatments. Washington, DC: American Psychiatric Press. In press
88. Purpura DP, Shofer RJ. Excitatory action of dibutyryl cyclic adenosine monophosphate on immature cerebral cortex. Brain Res 1972;38: 179-181
89. Boulton CL, McCrohan CR, O'Shaughnessy CT. Cyclic AMP analogues increase activity in rat neocortex in vitro. Eur J Pharmacol 1993;236: 131-136
90. Kuriyama K, Kakita K. Cholera toxin induced epileptogenic focus: an animal model for studying roles of cyclic AMP in the establishment of epilepsy. In: Baltistin L, ed. Neurochemistry and Clinical Neurology. New York, NY: Alan R. Liss; 1980:141-155
91. Ludvig N, Moshe SL. Different behavioral and electrographic effects of acoustic stimulation and dibutyryl cyclic AMP injection into the inferior colliculus in normal and in genetically epilepsy-prone rats. Epilepsy Res 1989;3:185-190
92. Ludvig N, Mishra PK, Yan QS, et al. The combined EEG-intracerebral microdialysis technique: a new tool for neuropharmacological studies on freely behaving animals. J Neurosci Methods 1992;43:129-137
93. Williams SF, Colling SB, Whittington MA, et al. Epileptic focus induced by intrahippocampal cholera toxin in rat: time course and properties in vivo and in vitro. Epilepsy Res 1993;16:137-146
94. Yokoyama N, Mori N, Kumashiro H. Chemical kindling induced by cAMP and transfer to electrical kindling. Brain Res 1989;492:158-162
95. Young LT, Li PP, Kish SJ, et al. Cerebral cortex Gs α protein levels and forskolin-stimulated cyclic AMP formation are increased in bipolar affective disorder. J Neurochem 1993;61:890-898
96. Young LT, Li PP, Kamble A, et al. Mononuclear leukocyte levels of G proteins in depressed patients with bipolar disorder or major depressive disorder. Am J Psychiatry 1994;151:594-596
97. Manji HK, Chen G, Shimon H, et al. Guanine nucleotide-binding proteins in bipolar affective disorder: effects of long-term lithium treatment. Arch Gen Psychiatry 1995;52:135-144
98. Palmer GC. Interactions of antiepileptic drugs on adenylate cyclase and phosphodiesterases in rat and mouse cerebrum. Exp Neurol 1979;63:322-335
99. Myllyla VV. Effect on convulsions and anticonvulsive drugs on cerebrospinal fluid cyclic AMP in rabbit. Eur Neurol 1976;14:97-107
100. Elphick M, Taghavi Z, Powell T, et al. Chronic carbamazepine down-regulates adenosine A2 receptors: studies with the putative selective adenosine antagonists PD115,199 and PD 116,948. Psychopharmacology (Berl) 1990;100:522-529
101. Van Calker D, Steber R, Klotz K, et al. Carbamazepine distinguishes between adenosine receptors that mediate different second messenger responses. Eur J Pharmacol Mol Pharmacol Sect 1991;206:285-290
102. Lewin E, Bleck V. Cyclic AMP accumulation in cerebral cortical slices: effect of carbamazepine, phenobarbital, and phenytoin. Epilepsia 1977; 18:237-242
103. Ferrendelli JA, Kinsherf DA. Inhibitory effects of anticonvulsant drugs on cyclic nucleotide accumulation in brain. Ann Neurol 1979;5:533-538
104. Post RM, Ballenger JC, Uhde TW, et al. Effect of carbamazepine on cyclic nucleotides in CSF of patients with affective illness. Biol Psychiatry 1982;17:1037-1045
105. Divish MM, Sheftel G, Boyle A, et al. Differential effect of lithium on fos prolo-oncogene expression mediated by receptor and postreceptor activators of protein kinase C and cyclic adenosine monophosphate: model for its antimanic action. J Neurosci Res 1991;28:40-48
106. Chen G, Pan B, Hawver DB, et al. Attenuation of cyclic AMP production by carbamazepine. J Neurochem 1996;67:2079-2087
107. Stiles G. Adenosine receptors. J Biol Chem 1992;267:6451-6454
108. Sheng M, Greenberg ME. The regulation and function of c-fos and other immediate early genes in the nervous system. Neuron 1991;4:447-485
109. Lee KA. Transcriptional regulation by cAMP. Curr Opin Cell Biol 1991; 3:953-959